Attached files

file filename
10-Q - FORM 10-Q - BIOLASE, INCc05030e10vq.htm
EX-10.5 - EXHIBIT 10.5 - BIOLASE, INCc05030exv10w5.htm
EX-31.1 - EXHIBIT 31.1 - BIOLASE, INCc05030exv31w1.htm
EX-10.3 - EXHIBIT 10.3 - BIOLASE, INCc05030exv10w3.htm
EX-10.7 - EXHIBIT 10.7 - BIOLASE, INCc05030exv10w7.htm
EX-10.6 - EXHIBIT 10.6 - BIOLASE, INCc05030exv10w6.htm
EX-10.4 - EXHIBIT 10.4 - BIOLASE, INCc05030exv10w4.htm
EX-10.2 - EXHIBIT 10.2 - BIOLASE, INCc05030exv10w2.htm
EX-10.1 - EXHIBIT 10.1 - BIOLASE, INCc05030exv10w1.htm
EXHIBIT 32.1
CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002*
Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, David M. Mulder, Chairman, Chief Executive Officer, and President of BIOLASE Technology, Inc. (the “Company”), hereby certify that to the best of my knowledge:
  (1)   This quarterly report on Form 10-Q for the quarter ended June 30, 2010 (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and,
  (2)   The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
         
Dated: August 16, 2010
  /s/ DAVID M. MULDER
 
David M. Mulder
   
 
  Chairman, Chief Executive Officer, and President    
 
  (Principal Executive Officer and Principal    
 
  Financial and Accounting Officer)    
     
*   This certificate accompanies this Report pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and shall not, except to the extent required by the Sarbanes-Oxley Act of 2002, be deemed filed by the Company for purposes of Section 18 of the Securities Exchange Act of 1934. A signed original of this written statement required by Section 906 of the Sarbanes-Oxley Act of 2002 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.